Generic name: methylphenidate
Used for: ADHD
Ask for the cash price
Authorized generic
Relexxii itself, without the brand name. It usually costs less than Relexxii.
Sold only in a different form, strength or formula. Switching to one would need a new prescription, so ask your prescriber whether it could work for you.
Details for each option
Relexxii’s maker has a savings card that lowers what you pay at the pharmacy.
Savings card from Vertical Pharmaceuticals
“Pay as Little as $0 per Month with Our Savings Card…”
From the maker’s offer on relexxii.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
The same medicine as Relexxii, without the brand name. Give the pharmacy its NDC to get it.
methylphenidate
Pick your strength to see just its NDC.
Source: FDA, updated October 30, 2026
“Before you fill my Relexxii, can you tell me what I’d pay for the brand, for the authorized generic from Trigen Laboratories (NDC )?”
Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.
Official labels and ingredient lists from DailyMed (U.S. National Library of Medicine).
63 mg extended-release tablet
Same active and inactive ingredients as Relexxii.
Active: methylphenidate hydrochloride 63 mg
Inactive, on both labels:
45 mg extended-release tablet
Same active and inactive ingredients as Relexxii.
Active: methylphenidate hydrochloride 45 mg
Inactive, on both labels:
Sold only in a different form, strength or formula. Switching to one would need a new prescription, so ask your prescriber whether it could work for you. Generics usually come once the brand’s patents and exclusivity end. Until then, the authorized generic is the lower-cost way to get Relexxii.
RELEXXII® is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults (up to the age of 65 years) and pediatric patients 6 years of age and older.
Limitations of Use
The use of RELEXXII is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage.
Source: the FDA label for Relexxii (Vertical Pharmaceuticals, LLC), September 26, 2025. Full label on DailyMed
Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/relexxii/